Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-Month and 12-month serial follow-up

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 4617-4623

  Kim, Byeong Keuk ^a   Hong, Myeong Ki ^a,b   Shin, Dong Ho ^a   Kim, Jung Sun ^a   Ko, Young Guk ^a   Choi, Donghoon ^a   Jang, Yangsoo ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Coronary artery disease; Drug eluting stent; Optical coherence tomography

Indexed keywords

RAPAMYCIN; UMIROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOLIMUS ELUTING STENT; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIROLIMUS ELUTING STENT; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

CORONARY ARTERY DISEASE; DRUG-ELUTING STENT; OPTICAL COHERENCE TOMOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REPRODUCIBILITY OF RESULTS; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 84886397754     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.160     Document Type: Article

References (24)

1. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441
2. A.V. Finn, G. Nakazawa, and M. Joner Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
3. G. Guagliumi, V. Sirbu, and G. Musumeci Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging J Am Coll Cardiol Intv 5 2012 12 20
4. G.J. Tearney, E. Regar, and T. Akasaka Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation J Am Coll Cardiol 59 12 2012 1058 1072
5. F. Prati, G. Guagliumi, and G.S. Mintz Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures Eur Heart J 33 2012 2513 2520
6. S. Windecker, P.W. Serruys, and S. Wandel Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet 372 2008 1163 1173
7. B. Chevalier, S. Silber, and S.J. Park Randomized comparison of the Nobori biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial-phase 2 Circ Cardiovasc Interv 2 2009 188 195
8. P. Barlis, E. Regar, and P.W. Serruys An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study Eur Heart J 31 2010 139 142
9. P.A. Davlouros, E. Mavronasiou, and I. Xanthopoulou An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9 Int J Cardiol 157 2012 341 346
10. M. Takano, S. Inami, and I.K. Jang Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation Am J Cardiol 99 2007 1033 1038
11. E. Grube, K.E. Hauptmann, L. Buellesfeld, V. Lim, and A. Abizaid Six-month results of a randomized study to evaluate safety and efficacy of a biolimus A9 eluting stent with a biodegradable polymer coating EuroIntervention 1 2005 53 57
12. J. Tanigawa, P. Barlis, K. Dimopoulos, M. Dalby, P. Moore, and C. Di Mario The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
13. J.L. Gutiérrez-Chico, P. Jüni, and H.M. García- García Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer Am Heart J 162 2011 922 931
14. B.K. Kim, D.H. Shin, and J.S. Kim Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation Int J Cardiovasc Imaging 28 2012 1887 1894
15. T. Kume, T. Akasaka, and T. Kawamoto Assessment of coronary arterial thrombus by optical coherence tomography Am J Cardiol 97 2006 1713 1717
16. J.S. Kim, M.K. Hong, and D.H. Shin Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT J Am Coll Cardiol Img 5 2012 1147 1155
17. J.S. Kim, I.K. Jang, and J.S. Kim Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents Heart 95 2009 1907 1912
18. J.S. Kim, M.K. Hong, and C. Fan Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study Am Heart J 159 2010 278 283
19. H. Doran, D. Bates, P. Bliese, and M. Dowling Estimating the multilevel Rasch model: with the lme4 package J Stat Softw 20 2007 1 18
20. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
21. A. Abizaid, and J.R. Costa Jr. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems Circ Cardiovasc Interv 3 2010 384 393
22. E. Grube, and L. Buellesfeld Biomatrix biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease Expert Rev Med Devices 3 2006 731 741
23. M.C. Ostojic, Z. Perisic, and D. Sagic The pharmacokinetics of biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK study Eur J Clin Pharmacol 67 2011 389 398
24. G.G. Stefanini, B. Kalesan, and P.W. Serruys Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial Lancet 378 2011 1940 1948